ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/20 | 3,945 | 3,950 | 3,815 | 3,820 | -125 | -3.2% | 1,219,500 |
| 2017/12/19 | 3,900 | 4,040 | 3,845 | 3,945 | +80 | +2.1% | 1,942,800 |
| 2017/12/18 | 3,845 | 3,880 | 3,820 | 3,865 | +45 | +1.2% | 1,232,000 |
| 2017/12/15 | 3,760 | 3,830 | 3,745 | 3,820 | +65 | +1.7% | 1,543,100 |
| 2017/12/14 | 3,700 | 3,775 | 3,690 | 3,755 | +75 | +2% | 972,000 |
| 2017/12/13 | 3,670 | 3,690 | 3,645 | 3,680 | +25 | +0.7% | 601,600 |
| 2017/12/12 | 3,635 | 3,680 | 3,620 | 3,655 | +20 | +0.6% | 580,000 |
| 2017/12/11 | 3,665 | 3,680 | 3,590 | 3,635 | +5 | +0.1% | 404,300 |
| 2017/12/08 | 3,570 | 3,650 | 3,570 | 3,630 | +15 | +0.4% | 639,100 |
| 2017/12/07 | 3,615 | 3,645 | 3,595 | 3,615 | +20 | +0.6% | 560,900 |
| 2017/12/06 | 3,600 | 3,665 | 3,575 | 3,595 | +15 | +0.4% | 724,200 |
| 2017/12/05 | 3,640 | 3,640 | 3,560 | 3,580 | -85 | -2.3% | 959,500 |
| 2017/12/04 | 3,735 | 3,830 | 3,655 | 3,665 | -85 | -2.3% | 1,377,600 |
| 2017/12/01 | 3,740 | 3,775 | 3,700 | 3,750 | +5 | +0.1% | 768,300 |
| 2017/11/30 | 3,740 | 3,775 | 3,690 | 3,745 | -15 | -0.4% | 1,001,800 |
| 2017/11/29 | 3,655 | 3,785 | 3,630 | 3,760 | +135 | +3.7% | 1,654,000 |
| 2017/11/28 | 3,645 | 3,655 | 3,590 | 3,625 | -50 | -1.4% | 621,000 |
| 2017/11/27 | 3,605 | 3,705 | 3,580 | 3,675 | +70 | +1.9% | 981,200 |
| 2017/11/24 | 3,530 | 3,640 | 3,515 | 3,605 | +75 | +2.1% | 834,700 |
| 2017/11/22 | 3,715 | 3,715 | 3,525 | 3,530 | -150 | -4.1% | 1,516,000 |
| 2017/11/21 | 3,640 | 3,735 | 3,615 | 3,680 | +45 | +1.2% | 1,663,300 |
| 2017/11/20 | 3,495 | 3,680 | 3,465 | 3,635 | +115 | +3.3% | 2,753,300 |
| 2017/11/17 | 3,500 | 3,575 | 3,430 | 3,520 | +280 | +8.6% | 3,524,100 |
| 2017/11/16 | 3,165 | 3,265 | 3,130 | 3,240 | +55 | +1.7% | 802,400 |
| 2017/11/15 | 3,230 | 3,335 | 3,165 | 3,185 | -30 | -0.9% | 1,429,800 |
| 2017/11/14 | 3,205 | 3,290 | 3,185 | 3,215 | +80 | +2.6% | 1,755,700 |
| 2017/11/13 | 3,200 | 3,210 | 3,065 | 3,135 | -95 | -2.9% | 1,756,300 |
| 2017/11/10 | 3,305 | 3,330 | 3,220 | 3,230 | -100 | -3% | 1,632,600 |
| 2017/11/09 | 3,480 | 3,485 | 3,285 | 3,330 | -205 | -5.8% | 3,174,900 |
| 2017/11/08 | 3,560 | 3,580 | 3,525 | 3,535 | -55 | -1.5% | 563,100 |
| 2017/11/07 | 3,515 | 3,595 | 3,505 | 3,590 | +40 | +1.1% | 682,200 |
| 2017/11/06 | 3,560 | 3,565 | 3,510 | 3,550 | -5 | -0.1% | 503,000 |
| 2017/11/02 | 3,600 | 3,600 | 3,535 | 3,555 | -30 | -0.8% | 555,600 |
| 2017/11/01 | 3,595 | 3,600 | 3,545 | 3,585 | -5 | -0.1% | 538,600 |
| 2017/10/31 | 3,490 | 3,595 | 3,490 | 3,590 | +90 | +2.6% | 980,600 |
| 2017/10/30 | 3,530 | 3,530 | 3,475 | 3,500 | -30 | -0.8% | 740,100 |
| 2017/10/27 | 3,505 | 3,555 | 3,495 | 3,530 | +25 | +0.7% | 396,300 |
| 2017/10/26 | 3,505 | 3,520 | 3,470 | 3,505 | -15 | -0.4% | 521,700 |
| 2017/10/25 | 3,600 | 3,610 | 3,515 | 3,520 | -95 | -2.6% | 670,200 |
| 2017/10/24 | 3,480 | 3,625 | 3,465 | 3,615 | +140 | +4% | 1,073,700 |
| 2017/10/23 | 3,495 | 3,495 | 3,455 | 3,475 | ±0 | ±0% | 451,200 |
| 2017/10/20 | 3,450 | 3,500 | 3,445 | 3,475 | -5 | -0.1% | 441,500 |
| 2017/10/19 | 3,525 | 3,525 | 3,460 | 3,480 | -45 | -1.3% | 438,000 |
| 2017/10/18 | 3,495 | 3,535 | 3,495 | 3,525 | +30 | +0.9% | 360,500 |
| 2017/10/17 | 3,565 | 3,565 | 3,485 | 3,495 | -70 | -2% | 573,800 |
| 2017/10/16 | 3,570 | 3,610 | 3,550 | 3,565 | -20 | -0.6% | 576,800 |
| 2017/10/13 | 3,545 | 3,595 | 3,515 | 3,585 | +40 | +1.1% | 797,400 |
| 2017/10/12 | 3,500 | 3,555 | 3,495 | 3,545 | +45 | +1.3% | 593,800 |
| 2017/10/11 | 3,440 | 3,520 | 3,440 | 3,500 | +45 | +1.3% | 537,700 |
| 2017/10/10 | 3,415 | 3,495 | 3,415 | 3,455 | -45 | -1.3% | 810,100 |
1801～
1850
件表示中 / 2911件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 184,600円 | +5.0% | +1.5% | 0.00% | 15.85倍 | 4.22倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 91,400円 | +26.8% | - | 0.00% | 15.39倍 | 3.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 368,800円 | +20.9% | +87.3% | 3.69% | 8.24倍 | 0.95倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 328,400円 | +8.0% | -15.3% | 3.78% | 9.22倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 197,000円 | +4.0% | +25.4% | 2.69% | 8.62倍 | 1.13倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
